Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Amphastar Pharmaceuticals, Inc.

NASDAQ: AMPH · Life Sciences · 2 alerts · CIK 1297184

Share price
$29.17Close, Nov 16
Market cap
$1.24B
Shares outstanding
42.65MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Amphastar Pharmaceuticals, Inc. filings on SEC EDGAR ↗

4:41 PM ET 10-Q
Financial Results

Amphastar Pharmaceuticals Q3 2026 Results: Net Income $37.8M, Up 117.7% YoY

Amphastar Pharmaceuticals reported total assets of $1.71 billion as of September 30, 2026, up from $1.63 billion at year-end 2025. The company maintained a strong liquidity position with $204.6 million in cash and cash equivalents, while total liabilities increased to $897.2 million, primarily driven by long-term debt and operating lease liabilities.

Key figure
Net income $37.8M · +117.7% YoY
4:32 PM ET 8-K
Financial Results

Amphastar Pharmaceuticals Financial Results

Amphastar Pharmaceuticals reported third quarter 2026 net revenues of $207.6 million, an 8% increase year-over-year driven by record sales of BAQSIMI and Primatene MIST. The company achieved GAAP net income of $37.8 million, or $0.87 per diluted share, significantly up from $17.4 million in the prior year period.

Term
3 months

“Our third quarter results demonstrate the strength of Amphastar’s diversified portfolio and the commercial platform we have built. Record sales of BAQSIMI® and Primatene MIST®, together with contributions from recently launched products, supported continued revenue growth and further strengthened the foundation for our long-term strategy.”

Dr. Jack Zhang, Amphastar’s President and Chief Executive Officer

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.